A detailed history of Resources Investment Advisors, Llc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Resources Investment Advisors, Llc. holds 51,073 shares of ABBV stock, worth $8.95 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
51,073
Previous 56,175 9.08%
Holding current value
$8.95 Million
Previous $9.64 Million 4.67%
% of portfolio
0.12%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$163.84 - $199.33 $835,911 - $1.02 Million
-5,102 Reduced 9.08%
51,073 $10.1 Million
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $1.52 Million - $1.78 Million
9,839 Added 21.23%
56,175 $9.64 Million
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $410,897 - $468,179
2,571 Added 5.87%
46,336 $8.44 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $749,920 - $844,586
-5,450 Reduced 11.07%
43,765 $6.78 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $608,769 - $704,740
4,557 Added 10.2%
49,215 $7.34 Million
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $165,637 - $206,125
-1,250 Reduced 2.72%
44,658 $6.02 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $472,296 - $543,919
3,266 Added 7.66%
45,908 $7.32 Million
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $599,712 - $719,212
4,336 Added 11.32%
42,642 $6.9 Million
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $664,742 - $762,415
4,953 Added 14.85%
38,306 $5.14 Million
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $418,640 - $532,228
-3,042 Reduced 8.36%
33,353 $5.11 Million
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $526,204 - $652,871
3,987 Added 12.3%
36,395 $5.9 Million
Q4 2021

Feb 23, 2022

SELL
$107.43 - $135.93 $50,599 - $64,023
-471 Reduced 1.43%
32,408 $4.39 Million
Q3 2021

Nov 05, 2021

BUY
$106.4 - $120.78 $49,688 - $56,404
467 Added 1.44%
32,879 $3.55 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $74,699 - $83,219
710 Added 2.24%
32,412 $3.65 Million
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $71,712 - $78,946
701 Added 2.26%
31,702 $3.43 Million
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $245,655 - $331,660
-3,052 Reduced 8.96%
31,001 $3.32 Million
Q3 2020

Oct 09, 2020

BUY
$85.91 - $100.83 $192,782 - $226,262
2,244 Added 7.05%
34,053 $2.98 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $95,967 - $128,419
1,308 Added 4.29%
31,809 $3.12 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $131,580 - $199,491
2,040 Added 7.17%
30,501 $2.32 Million
Q4 2019

Feb 07, 2020

SELL
$72.13 - $90.25 $1,803 - $2,256
-25 Reduced 0.09%
28,461 $2.52 Million
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $351,365 - $422,441
-5,579 Reduced 16.38%
28,486 $2.16 Million
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $1.27 Million - $1.62 Million
19,349 Added 131.48%
34,065 $0
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $99,587 - $117,209
1,291 Added 9.62%
14,716 $0
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $3,425 - $4,224
-44 Reduced 0.33%
13,425 $1.24 Million
Q3 2018

Nov 07, 2018

BUY
$88.91 - $98.84 $71,394 - $79,368
803 Added 6.34%
13,469 $1.27 Million
Q2 2018

Aug 15, 2018

SELL
$89.78 - $106.23 $131,258 - $155,308
-1,462 Reduced 10.35%
12,666 $1.17 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $27,050 - $36,223
-294 Reduced 2.04%
14,128 $1.34 Million
Q4 2017

Jan 31, 2018

BUY
$89.56 - $98.21 $221,929 - $243,364
2,478 Added 20.75%
14,422 $1.39 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $88,849 - $113,487
1,272 Added 11.92%
11,944 $1.06 Million
Q2 2017

Aug 14, 2017

BUY
N/A
10,672
10,672 $774,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Resources Investment Advisors, Llc. Portfolio

Follow Resources Investment Advisors, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Resources Investment Advisors, Llc. with notifications on news.